6 results match your criteria: "and German Centre for Diabetes Research[Affiliation]"

Aim: To determine the prevalence of inflammatory bowel disease (IBD) in patients with type 1 diabetes (T1D) and to characterise patients with both diseases.

Methods: Data of 65.147 patients with T1D ≤18 years of 379 centres in Germany and Austria participating in the DPV initiative were analysed.

View Article and Find Full Text PDF
Article Synopsis
  • The global rise in diabetes cases is linked to β-cell dysfunction, which affects insulin production in both type 1 and type 2 diabetes.
  • Traditional drug evaluations in the pharmaceutical industry rely on cell lines and rodent models, which do not accurately replicate human islet function, limiting the predictive power for new diabetes treatments.
  • The innovative Engineered Micro-Pancreas, utilizing a decellularized lung-derived scaffold and human islets, shows promising viability and insulin secretion comparable to human islets, paving the way for more effective drug discovery methods.
View Article and Find Full Text PDF

Transplantation of pancreatic islets is a promising strategy to alleviate the unstable blood-glucose control that some patients with diabetes type 1 exhibit and has seen many advances over the years. Protection of transplanted islets from the immune system can be accomplished by encapsulation within a hydrogel, the most investigated of which is alginate. In this study, islet encapsulation is combined with 3D extrusion bioprinting, an additive manufacturing method which enables the fabrication of 3D structures with a precise geometry to produce macroporous hydrogel constructs with embedded islets.

View Article and Find Full Text PDF

Objective: To evaluate the impact of self-reported chronic-generic and condition-specific quality of life (QoL) on glycemic control among adolescents and emerging adults with long-duration type 1 diabetes (T1D) in a longitudinal design.

Methods: The database used was a nationwide cohort study of patients with ≥10 years T1D duration at baseline in Germany. The baseline questionnaire survey was conducted in 2009-2010, the follow-up survey in 2012-2013; additional clinical data of routine care procedures were linked.

View Article and Find Full Text PDF

Sex Hormones and Sleep in Men and Women From the General Population: A Cross-Sectional Observational Study.

J Clin Endocrinol Metab

November 2016

Institute of Clinical Chemistry and Laboratory Medicine (H.K., H.W., M.N., R.H.), Departments of Internal Medicine B (R.E., A.O., B.S.) and Cardiology (S.G., M.D.), and Institute for Community Medicine (H.V.), University Medicine Greifswald, D-17475 Greifswald, Germany; Interdisciplinary Sleep Center (I.F., T.P.), Charité, University Medicine, 10117 Berlin, Germany; German Centre for Cardiovascular Research (S.G., H.V., M.D., M.N.) and German Centre for Diabetes Research (H.V.), partner site Greifswald, 13092 Greifswald, Germany; and Faculty of Applied Public Health (R.H.), European University of Applied Sciences, 18051 Rostock, Germany.

Context And Objectives: Associations between sex hormones and sleep habits originate mainly from small and selected patient-based samples. We examined data from a population-based sample with various sleep characteristics and the major part of sex hormones measured by mass spectrometry.

Design, Setting, And Participants: We used data from 204 men and 213 women of the cross-sectional Study of Health in Pomerania-TREND.

View Article and Find Full Text PDF

The two incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP1), were discovered 45 and 30 years ago. Initially, only their insulinotropic effect on pancreatic β cells was known. Over the years, physiological and pharmacological effects of GIP and GLP1 in numerous extrapancreatic tissues were discovered which partially overlap, but may also be specific for GIP or GLP1 in certain target tissues.

View Article and Find Full Text PDF